Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11312699 Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Patent 11312699 was granted and assigned to Celgene on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Gregg Feigelson0
Jianxin Han0
Joshua Hansen0
Marie G. Beauchamps0
Michael J. Zacuto0
Michael James Williams0
Mohit A. Kothare0
Weihong Zhang0
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Celgene
Celgene
0
Current Assignee
Celgene
Celgene
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113126990
Date of Patent
April 26, 2022
0
Patent Application Number
171128020
Date Filed
December 4, 2020
0
Patent Citations
‌
US Patent 11129821 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 10052315 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 10189808 Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
0
‌
US Patent 10245258 Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 10449187 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 10626101 Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
0
Patent Primary Examiner
‌
Patricia L Morris
0
CPC Code
‌
C07D 401/04
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 19 May, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 May, 2022
Edits made to:
Infobox (+16 properties)
Article (+146 characters)
‌

 US Patent 11312699 Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Article

Provided herein are processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide.

Infobox
Is a
Patent
Patent
Patent applicant
Celgene
Celgene
Current assignee
Celgene
Celgene
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11312699
Date of patent
April 26, 2022
Patent application number
17112802
Date Filed
December 4, 2020
Patent citations
‌
US Patent 11129821 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
‌
US Patent 10052315 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
‌
US Patent 10189808 Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
‌
US Patent 10245258 Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
‌
US Patent 10449187 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
‌
US Patent 10626101 Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
Patent primary examiner
‌
Patricia L Morris
CPC Code
‌
C07D 401/04

Find more entities like US Patent 11312699 Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo